Anne H Bates

Title: The Innovations of Anne H Bates

Introduction

Anne H Bates is a notable inventor based in LaFayette, California. She has made significant contributions to the field of biotechnology, particularly in the development of high affinity monoclonal antibodies. With a total of three patents to her name, her work has advanced the understanding and application of Bowman-Birk inhibitor (BBI).

Latest Patents

Among her latest patents, Bates has developed high affinity monoclonal antibodies to Bowman-Birk inhibitor. These antibodies possess unique characteristics, such as specificity to the active form of BBI, which allows them to react and bind with undenatured BBI while avoiding denatured forms. Additionally, these antibodies do not react with Kunitz-type inhibitors and can distinguish classical BBI from other variants, including the lima bean protease inhibitor. Furthermore, they are capable of binding to BBI-protease complexes, such as BBI-chymotrypsin. Bates has also described immunoassay methods that utilize these monoclonal antibodies to analyze BBI in various biological tissues and foodstuffs.

Career Highlights

Bates has dedicated her career to advancing the field of immunology through her innovative research. Her work has not only contributed to scientific knowledge but has also paved the way for practical applications in diagnostics and therapeutics.

Collaborations

Some of her notable coworkers include David L Brandon and Mendel Friedman, who have collaborated with her on various projects related to her patents.

Conclusion

Anne H Bates is a pioneering inventor whose work on high affinity monoclonal antibodies has made a significant impact in the field of biotechnology. Her contributions continue to influence research and applications in immunology.